MedPath

Elevation of functional and structural tissue parameters of the kidneys in magnetic resonance imaging in patients at risk for the development of nephropathy: a pilot study

Not Applicable
Conditions
N14.1
Nephropathy induced by other drugs, medicaments and biological substances
Registration Number
DRKS00018966
Lead Sponsor
niversitätsklinikum Tübingen, Radiologische Klinik, Diagnostische & Interventionelle Radiologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
24
Inclusion Criteria

Perform kidney scintigraphy for a clinical indication (relevant risk of developing renal damage due to planned potential nephrotoxic therapy (e.g., radiotherapy)),
• Age =18 years,
• Written consent of the patient.

Exclusion Criteria

Pregnant / lactating women,
Presence of non-MRI-compatible implants or any type of metal in and on the body, (e.g., pacemakers, artificial heart valves, metal prosthesis, implanted magnetic metal parts, spiral, etc.),
patients who report hearing disorder or increased sensitivity to loud noises,
patients with limited temperature sensation and / or increased sensitivity to warming of the body,
patients who suffer from claustrophobia,
obesity >150 kg body weight,
patients who do not want to be informed about incidental findings,
limited ability to consent of the patient.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recording of potential morphological and functional changes of the renal parenchyma by means of fMRI and the subsequent correlation of the MR data with the reference standard (various laboratory parameters, kidney scintigraphy, if necessary follow-up).
Secondary Outcome Measures
NameTimeMethod
Development of a score using MRI, laboratory parameters and scintigraphy to predict the likelihood of later onset of nephropathy (predictive value).
© Copyright 2025. All Rights Reserved by MedPath